Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
- 8 November 2002
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (23) , 1589-1599
- https://doi.org/10.1038/sj.gt.3301895
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PSP94 EXPRESSION AFTER ANDROGEN DEPRIVATION THERAPY: A COMPARATIVE STUDY WITH PROSTATE SPECIFIC ANTIGEN IN BENIGN PROSTATE AND PROSTATE CANCERJournal of Urology, 2000
- GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?Journal of Urology, 2000
- PSP94: Evaluation of Prognostic Utility in Patients Treated with Radiotherapy for Nonmetastatic Prostate CancerThe Prostate Journal, 2000
- Mouse models of prostate cancerOncogene, 1999
- cDNA, Genomic Cloning, and Gene Expression Analysis of Mouse PSP94 (Prostate Secretory Protein of 94 Amino Acids)DNA and Cell Biology, 1999
- Molecular Cloning and Gene Expression Analysis of PSP94 (Prostate Secretory Protein of 94 Amino Acids) in PrimatesDNA and Cell Biology, 1997
- Prostate-specific Antigen Expression Is Regulated by an Upstream EnhancerJournal of Biological Chemistry, 1996
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995
- Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.Proceedings of the National Academy of Sciences, 1994
- Heterologous introns can enhance expression of transgenes in mice.Proceedings of the National Academy of Sciences, 1991